SNX Form 4: Chief Legal Officer sells 1,139 shares in October

Rhea-AI Filing Summary

Insider sales by TD SYNNEX Chief Legal Officer: The filing shows that David R. Vetter, Chief Legal Officer and officer of TD SYNNEX (SNX), reported two open-market dispositions of common stock in early October. On 10/03/2025 he sold 734 shares at $158.66, and on 10/06/2025 he sold 405 shares at $157.84, reducing his holdings from 65,119 to 64,714 shares. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Positive

• Timely compliance with Section 16 reporting shown by a filed Form 4 signed on 10/07/2025
• Full disclosure of transaction details including share counts and prices ($158.66 and $157.84)

Negative

• Officer dispositions totaling 1,139 shares, reducing direct holdings from 65,119 to 64,714
• No 10b5-1 plan indicated on the form (checkbox not marked), which may merit attention if more sales follow

Insights

Corporate Governance Analyst

TL;DR: Officer reported modest open-market share sales, with full Section 16 disclosure.

These transactions are routine officer dispositions: 1,139 shares were sold across two trades on 10/03/2025 and 10/06/2025, lowering direct beneficial ownership from 65,119 to 64,714 shares. The Form 4 documents the sales prices at $158.66 and $157.84, consistent with open-market activity.

Risks and monitoring items are limited: there is no indication of a Rule 10b5-1 plan checkbox checked, and the filing shows timely reporting through an attorney-in-fact on 10/07/2025. Investors may monitor future filings for pattern changes in insider trading activity within the next several weeks.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VETTER DAVID R

(Last) (First) (Middle)

5350 TECH DATA DRIVE

(Street)

CLEARWATER FL 33760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/03/2025		F		734	D	$158.66	65,119	D
Common Stock	10/06/2025		F		405	D	$157.84	64,714	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Cheryl Grant, attorney-in-fact	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did TD SYNNEX (SNX) report on this Form 4?

The Form 4 reports that Chief Legal Officer David R. Vetter sold 734 shares on 10/03/2025 at $158.66 and 405 shares on 10/06/2025 at $157.84.

How did David R. Vetter's ownership change after the reported trades?

Reported direct beneficial ownership decreased from 65,119 shares to 64,714 shares, a net reduction of 1,139 shares.

Was the sale reported as part of a 10b5-1 trading plan?

No. The form does not indicate a transaction pursuant to a Rule 10b5-1 plan (the plan checkbox is not marked).

When was the Form 4 filed and who signed it?

The Form 4 was dated and signed by Cheryl Grant, attorney-in-fact on 10/07/2025.

What prices were the shares sold at according to the filing?

The filing lists sale prices of $158.66 (10/03/2025) and $157.84 (10/06/2025).